A Legacy of Excellence
ATCO’s journey has been a testament to its commitment to excellence, diversification, and innovation. From its roots in pharmaceuticals to expansion in nutraceutical and dermacosmetic products, and medical devices, ATCO continues to evolve, leaving an indelible mark on Pakistan’s healthcare industry.
Driven by a passion to shape healthcare industry with high quality products, and customer excellence, ATCO Group continues to grow and evolve, meeting the ever-changing demands of the global market.
Established in 1978 ATCO quickly gained recognition for its dedication to producing high-quality products that addressed the diverse needs of its customers.
1978 was a significant year in the history of ATCO when it was acquired by one of the largest privately owned business in Pakistan –The Kohinoor Group
Established in pre-partition India in the year 1940 The Kohinoor group is renowned for its diverse portfolio, including high-quality soaps, cosmetics, toiletries, pharmaceuticals, dry battery cells, flexible packaging, and IT services.
This strategic acquisition propelled the company to new heights of success and enabled it to expand its reach across various sectors.
ATCO Group’s journey of over 40 years has been defined by a relentless commitment to innovation and excellence across its pharmaceutical, nutraceutical, medical devices and dermacosmetic divisions.
1978
was a significant year in the history of ATCO when it was acquired by one of the largest conglomerate business groups of Pakistan The Kohinoor Group, having successful businesses in diverse industries such as cosmetics, personal care, battery cells, soaps, detergents, etc.
1978
1991
In 1991, the company expanded its horizons by venturing into International markets, marking a significant milestone in its growth.
1991
2000
In the year 2000, the company achieved ISO 9002 Certification, showcasing its commitment to quality and excellence
2000
2009
In 2009, ATCO further expanded its influence with the establishment of Medinostic Healthcare (Private) Limited, a division dealing in the areas of infection control and medical simulation & teaching aids.
2009
2013
The year 2013 marked the groundbreaking for a new plant, setting the Foundation for future expansion, highlighting ATCO’s strategic vision and commitment to continued growth and development.
2013
2016
A new chapter unfolded in 2016 with the inception of ATCO Healthcare, specializing in herbal and nutraceutical products, diversifying ATCO’s healthcare portfolio.
2016
2017
ATCO expanded its operations in the Semi-solid area in 2017, enhancing its production capabilities and product offerings to meet growing market demands.
2017
2019
ATCO expanded its operations in the Oral Solid Dosage area in 2019, further diversifying its pharmaceutical product range and strengthening its position in the industry.
2019
2023
In 2023, ATCO reached a new milestone with the establishment of a Sterile manufacturing area, expanding its capabilities in specialized pharmaceutical production.
2023
2024
In 2024, ATCO continued its expansion in healthcare industy with the establishment of ATCO Life Sciences, specializing in high-quality dermacosmetic products.
2024
Leading the Way ForwardLeading
As we propel into the future, we envision ATCO expanding its global footprint, pioneering innovative solutions, and setting new benchmarks of excellence across the pharmaceutical, nutraceutical, medical devices and dermacosmetic industries. Together, we embark on this journey, united in our vision to create a better tomorrow through excellence and integrity.